Caplacizumab Model‐Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura

Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare and life‐threatening autoimmune thrombotic microangiopathy. Caplacizumab, evaluated in phase II and III studies in adults, shortens the time to platelet count response and reduces aTTP exacerbations, has a favorable safety profile, and ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergstrand, Martin, Hansson, Emma, Delaey, Bernard, Callewaert, Filip, De Passos Sousa, Rui, Sargentini‐Maier, Maria Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Pediatric Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255589/
https://www.ncbi.nlm.nih.gov/pubmed/34699078
http://dx.doi.org/10.1002/jcph.1991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255589/
https://www.ncbi.nlm.nih.gov/pubmed/34699078
http://dx.doi.org/10.1002/jcph.1991

Ejemplares similares